Matches 301 - 350 out of 492 < 1 2 3 4 5 6 7 8 9 10 >
Match Document Document Title
5370864 Breath protection microcapsules  
The present invention relates to oral compositions in the form of microcapsules which reduce oral bacteria and provide long lasting breath protection.
5340566 Method for preventing the progression of gingivitis  
A method is disclosed for treating and preventing gingivitis involving a patient desiring to prevent the progression of gingivitis the method comprising brushing the patient's teeth with a...
5330761 Bioadhesive tablet for non-systemic use products  
The present invention relates to a controlled release bioadhesive tablet which includes a locally active agent, a heterodisperse gum matrix, and a pharmaceutically acceptable diluent. In certain...
5326569 Medical foods for the nutritional support of child/adult metabolic diseases  
The present invention relates generally to a novel generic powder base rich in fats, carbohydrates, vitamins, minerals and trace elements which can be readily admixed with specific amino acids to...
5324751 Cryoprotectant sorbitol crystal spherules  
Free-flowing formations of spherules of loose knit microcrystals of the polymorphs of sorbitol and mannitol are useful in fast-frozen food products as cryoprotectants due to their improved rate of...
5322693 Lactoneotrehalose, and its preparation and uses  
Lactoneotrehalose, a novel saccharide shown by the formula O-β-D-galactopyranosyl-(1➝4)-O-β-D-glucopyranosyl α-D-glucopyranoside, is prepared by allowing a saccharide-transferring enzyme to...
5322694 Pharmaceutical lozenges  
The present invention is directed to gelatin treated polyhydric alcohol compositions, their preparation, and to pharmaceutical lozenges prepared therefrom. The pre-granulation of a polyhydric...
5302394 Dextromethorphan continuous lozenge manufacturing process  
A process for producing a palatable dextromethorphan medicated hard candy lozenges on a continuous system comprising suspending dextromethorphan HBr adsorbate in a liquid suspension and adding this...
5296217 Methods for preventing dental calculus in domestic animals  
The novel agents for preventing dental calculus in domestic animals of the present invention are sequestering agents that are applied as coatings to commercially-prepared diets for domestic animals...
5294449 Composition of anti-cavity chewing gum and method of fighting tooth decay by using erythrose as anticaries agent  
A chewing gum formulation to fight cavities comprises sufficient erythrose to give the chewing gum anti-caries properties. Also disclosed is a method of reducing or preventing dental caries by...
5292528 Oral Composition  
There is disclosed an oral composition including an organosilicon-type quaternary ammonium salt immobilized on a water-insoluble solid carrier. In particularly, an oral composition in an aqueous...
5288498 Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments  
Compositions and methods of manufacture for producing a medicament composition capable of absorption through the mucosal tissues of the mouth, pharynx, and esophagus. The present invention relates...
5288497 Compositions of oral dissolvable medicaments  
Compositions and methods of manufacture for producing a medicament composition capable of absorption through the mucosal tissues of the mouth, pharynx, and esophagus. The present invention relates...
5286748 General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity  
Compositions and a general method are described to shorten the duration of common colds by administration of medicaments to and into the oral tissues, rather than to the nose, or by injection or by...
5286489 Taste masking compositions  
This disclosure relates to drug-polymer matrix compositions comprising an active ingredient having an amine or amido group and a pharmaceutically acceptable copolymer having a plurality of...
5281421 Gemfibrozil formulations  
Improved oral formulations are prepared by admixing gemfibrozil with from 1 to 4%, by weight, of a pharmaceutically acceptable surfactant having an HLB value of from about 10 to about 50.
5281410 Methods of reducing plaque and gingivitis with reduced staining  
Compositions for/methods of reducing plaque and gingivitis with reduced staining.
5273754 Appetite suppressant composition and method relating thereto  
There is disclosed an appetite suppressant composition for oral administration. The composition includes a heating and a cooling carminative substance, and may also include an amino acid and an...
5273753 Edible composition containing a polysacchride-producing enzyme  
A functional food which comprises a glucosyltransferase and/or a fructosyltransferase each having a water-soluble polysaccharide production ability, and a base therefor.
5272166 Method for selective reduction of Lp(a)  
The present invention relates to methods and corresponding agents for lowering plasma Lp(a) levels by the administration of agents that reduce Lp(a) and selectively separate therefrom the apo(a)...
5270031 Dentinal desensitizing compositions  
A composition containing a water soluble or water swellable polyelectrolyte or salts thereof in a dentifrice base or other oral compositions which can be used for relieving pain and discomfort...
5250569 Amino acid flavorings of aluminum astringent for oral use  
Formulations of aluminum compounds with select amino acids such as glycine (aminoacetic acid) in a base material are described. The base material can be a sweetening agent such as a hard or soft...
H001228 Medicated lollipop  
A solid form of medication is in the form of a lollipop. The lollipop includes two spherical portions, one located inside the other. The inner portion can include medicine or candy.
5225197 Pharmaceutical formulation  
A chewable tablet comprises a medicament dispersed in a chewable base, such as mannitol, together with an effervescent couple, such as citric acid - sodium bicarbonate. The combination of...
5223259 Securing means for an oral medicament and support therefor  
An oral medicament adapted to be administered on a support which allows sucking of the medicament while preventing inadvertent swallowing of the medicament in its entirety or in large pieces, as...
5215750 L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control  
Compositions comprising L-glutamine in combination with vitamins, minerals, choline, and flavonoids are disclosed. Such compositions can be administered to effect weight reduction, or to aid in...
5213615 Dental material and method for the control of caries and paradentitis  
A dental material for the control of caries and paradentitis is described, which contains an active agent combination of thymol and/or carvacrol and chlorhexidine and/or the physiologically...
5213803 Antiviral composition and method  
A method utilizing compositions for topical application which are adapted for the prevention and treatment of viral infections such as Herpes, AIDS and other envelope virus infections are...
5208039 Nutrient compositions deprived of methionine and supplemented with homocysteine  
Synthetic or semisynthetic nutrient composition intended to inhibit the development and the dissemination of malignant tumors in mammals, which composition is characterized in that it is deprived...
5206025 Porous pharmaceutical form and its preparation  
New porous, unitary freeze-dried pharmaceutical form, of homogeneous appearance, consisting of: a) an inclusion compound comprising: one or optionally more active substances, a...
5204115 Directly compressible xylitol and method  
A directly compressible xylitol granulate comprising xylitol and a physiologically acceptable, non-cariogenic binder taken from the group consisting of polymerized reducing sugars, an alkali...
5188825 Freeze-dried dosage forms and methods for preparing the same  
A method of preparing a freeze-dried dosage form including a water soluble active agent is disclosed. The water soluble active agent is bonded to an ion exchange resin to form a substantially water...
5188817 Method of treatment for periodontitis  
A method of treatment for periodontitis comprises the topical or systemic administration of a pharmaceutical composition containing at least one retinoid compound other than Vitamin A. Preferred...
5185153 Agents effecting the lysis of oral bacteria  
The present invention provides compositions for the lysis and killing of microbes in general, and in particular provides oral compositions for the lysis and killing oral bacteria. The compositions...
5182099 Preparation for prevention of emission of mercury from amalgam fillings and method  
A method of preventing or decreasing the emission of mercury vapor in the mouth, from a mercury amalgam filling, comprising contacting the amalgam filling with an oral composition containing sulfur...
5182114 Sugar compositions with molasses-containing fraction of cane sugar as a source of fluoride ion  
Non-cariogenic sugar composition comprising 2 to 10 ppm fluoride, and preferably 50 to 400 mg/100 g each of calcium ion and phosphate (calculated as P) and 5 to 50 mg/100 g magnesium. The...
5178850 Crystalline sugar alcohol containing uniformly dispersed liquid pharmaceutical compound  
A pharmaceutical composition comprising a crystalline sugar alcohol derived from at least one mono- or polysaccharide having at least one liquid pharmaceutically active compound uniformly dispersed...
5171575 Process for preventing diarrhea in animals  
There is disclosed a pharmaceutical composition for animals comprising at least one of a vinegar, a flesh of Japanese apricot, oranges, tomatoes and strawberries; and saccharides or a combination...
5167964 Semi-enteric drug delivery systems and methods for preparing same  
The present invention pertains to semi-enteric drug delivery systems which comprise (a) an inert core, (b) a first coating layer over the core comprising a medicament, and (c) a second coating...
5166142 Use of type IA antiarrhythmic agents to lower blood lipids  
A method is provided to lower serum cholesterol, total triglycerides and/or apoprotein B in a human by administering an effective amount of one or more Type IA antiarrhythmic agents to said human.
5158765 Hair removal composition  
A depilatory composition for the removal of hair is composed of a mixture of sugar, water and aspirin. This mixture is heated to dissolve the solute materials, and then allowed to cool so as to...
5156845 Dry mouth lozenge  
A dry mouth lozenge comprising a base, a pharmaceutically acceptable acedulate, such as a natural sweetener, betaine hydrochloride and a phramaceutically acceptable fluoride.
5154927 Gum composition containing dispersed porous beads containing active chewing gum ingredients and method  
A chewing gum that contains porous polymeric beads impregnated with active gum ingredients together with a method of making such a chewing gum.
5149521 Composition for use in oral cavity  
A composition for use in the oral cavity comprising (A) an easily breakable granule, (B) menthol and/or a natural substance containing menthol, and (C) a flavoring component such as basil, laurel,...
5135757 Compressible sustained release solid dosage forms  
A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes heteropolysaccharide...
5134162 Method for lowering high blood cholesterol levels in hyperlipidemic animals and confections as the ingestion medium  
A process for lowering the blood cholesterol of hyperlipidemic patients by oral ingestion of pyruvate and a confection (cereal bar, fruit bar, candy) containing pyruvate as the ingestion medium.
5132114 Compositions and methods of manufacture of compressed powder medicaments  
Compositions and methods of manufacture for producing a medicament composition capable of absorption through the mucosal tissues of the mouth, pharynx, and esophagus. The present invention relates...
5130146 Fluoride colloid and oral composition  
A colloidal solution comprises a fluoride(s) being difficultly soluble in water comprises colloidal particles of the fluoride having a particle size of 0.005 to 1 micron, said fluoride having a...
5128143 Sustained release excipient and tablet formulation  
A slow release pharmaceutical excipient of an inert diluent and a hydrodrophilic material including xanthan gum and a galactomannan gum capable of cross-linking the xanthan gum in the presence of...
5124156 Chewing gum for preventing pyorrhea alveolaris  
A chewing gum for preventing pyorrhea alveolaris contains 0.2 to 3.0% of lysozyme of egg white and 0.05 to 0.5% of mace extract.
Matches 301 - 350 out of 492 < 1 2 3 4 5 6 7 8 9 10 >